Literature DB >> 10340785

Lectin cytochemistry of the lacrimal sac epithelium in experimental dacryocystitis.

S Maeda1, M Ishikawa, T Abe, S Konno, S Sakuragi.   

Abstract

PURPOSE: To study the glycoconjugates in the lacrimal sac epithelium of Japanese white rabbits with experimentally induced chronic dacryocystitis.
METHODS: Chronic dacryocystitis was induced by a subcutaneous injection of albumin followed by an injection of Staphylococcus aureus into the lacrimal sac. The histological appearance of the lacrimal sac was studied using the alcian blue-periodic acid-Schiff sequence. In addition, the specific binding to the lacrimal sac epithelium of Ulex europaeus agglutinin 1, Ricinus communis agglutinin 1, peanut agglutinin, and soybean agglutinin was also studied.
RESULTS: Staining with alcian blue-periodic acid-Schiff sequence showed hyperplasia of the goblet cells in the inflamed lacrimal sac epithelium. Lectin cytochemistry revealed specific binding of Ulex europaeus agglutinin 1, Ricinus communis agglutinin 1, peanut agglutinin, and soybean agglutinin to the lacrimal sac epithelium.
CONCLUSIONS: These results indicated that the composition of glycoconjugates in the lacrimal sac epithelium is markedly changed in dacryocystitis. There seems to be a fundamental abnormality in glycoconjugate synthesis in the chronically inflamed lacrimal sac epithelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340785     DOI: 10.1016/s0021-5155(98)00076-8

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  Structural changes in the lacrimal sac epithelium and associated lymphoid tissue during experimental dacryocystitis.

Authors:  Makoto Ishikawa; Masabumi Kubo; Seiji Maeda; Yu Sawada; Eiichi Uchio; Takeshi Yoshitomi
Journal:  Clin Ophthalmol       Date:  2011-10-31

2.  Modeling Chronic Dacryocystitis in Rabbits by Nasolacrimal Duct Obstruction with Self-Curing Resin.

Authors:  Kai Hou; Tao Ai; Rong Liu; Nan Xiang; Jing Jin; Weikun Hu; Ban Luo
Journal:  J Ophthalmol       Date:  2017-06-22       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.